These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23564195)

  • 1. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.
    Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S
    Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
    Kimura T; Ito M; Onozawa S
    J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.
    Garbino J; Sommer R; Gerber A; Regamey C; Vernazza P; Gennè D; Dür P; Rothen M; Unger JP; Lew D
    Int J Infect Dis; 2002 Dec; 6(4):288-93. PubMed ID: 12718823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
    Patel T; Pearl J; Williams J; Haverstock D; Church D
    Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.
    Lim WS; Macfarlane JT; Boswell TC; Harrison TG; Rose D; Leinonen M; Saikku P
    Thorax; 2001 Apr; 56(4):296-301. PubMed ID: 11254821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection.
    Schneeberger PM; Dorigo-Zetsma JW; van der Zee A; van Bon M; van Opstal JL
    Scand J Infect Dis; 2004; 36(4):269-73. PubMed ID: 15198183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community acquired pneumonia - treatment options according to the international recommendations].
    Lewandowska K; Kuś J
    Wiad Lek; 2016; 69(2 Pt 1):139-44. PubMed ID: 27421128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Community acquired pneumoniae and chronic obstructive pulmonary disease: the RWE analysis of events that required hospitalizations, and healthcare integrated costs.].
    Ronconi G; Dondi L; Calabria S; Piccinni C; Pedrini A; Dondi L; Dell'Anno I; Esposito I; Addesi A; Viale P; Martini N
    Recenti Prog Med; 2023 Apr; 118(4):204-221. PubMed ID: 36971159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of bacterial etiology with conventional and multiplex PCR methods in adult patients with community-acquired pneumonia].
    Kurutepe S; Ecemiş T; Ozgen A; Biçmen C; Celik P; Aktoğu Özkan S; Sürücüoğlu S
    Mikrobiyol Bul; 2012 Oct; 46(4):523-31. PubMed ID: 23188566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.
    Torres A; Blasi F; Peetermans WE; Viegi G; Welte T
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1065-79. PubMed ID: 24532008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Wilson R
    Infection; 2016 Feb; 44(1):65-76. PubMed ID: 26370552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia.
    Costa MI; Cipriano A; Santos FV; Valdoleiros SR; Furtado I; Machado A; Abreu M; Bastos HN
    Pulmonology; 2022; 28(5):358-367. PubMed ID: 33358259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ; Zaidi STR
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of community-acquired pneumonia of bacterial etiology in adults.
    Sopena N; Sabrià M; Pedro-Botet ML; Manterola JM; Matas L; Domínguez J; Modol JM; Tudela P; Ausina V; Foz M
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):852-8. PubMed ID: 10691195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].
    Liu YN; Chen MJ; Zhao TM; Wang H; Wang R; Liu QF; Cai BQ; Cao B; Sun TY; Hu YJ; Xiu QY; Zhou X; Ding X; Yang L; Zhuo JS; Tang YC; Zhang KX; Liang DR; Lü XJ; Li SQ; Liu Y; Yu YS; Wei ZQ; Ying KJ; Zhao F; Chen P; Hou XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):3-8. PubMed ID: 16638292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.